Clinical Trials · NCT01593137
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- Fundación Fernández-Cruz
- Enrollment
- 0
- Start date
- May 2012
- Locations
- 1 site, Spain
- Primary endpoint
- assess the effect of treatment with liraglutide compared to glimepiride, as add-on to metformin, for one year on circulating levels of EPCs in patients with type 2 diabetes poorly controlled.